ENTRY       D11503                      Drug
NAME        Tomaralimab (USAN)
FORMULA     C6452H9958N1706O2028S44
EXACT_MASS  145193.6239
MOL_WEIGHT  145283.1763
SEQUENCE    (Heavy chain)
            QVQLVQSGSE LKKPGASVKL SCKASGFTFT TYGINWVRQA PGQGLEWIGW IYPRDGSTNF
            NENFKDRATI TVDTSASTAY MELSSLRSED TAVYFCARLT GGTFLDYWGQ GTTVTVSSAS
            TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
            FSCSVMHEAL HNHYTQKSLS LSLGK
            (Light chain)
            DIVLTQSPAT LSLSPGERAT LSCRASESVE YYGTSLMQWY QQKPGQPPKL LIFGASNVES
            GVPDRFSGSG SGTDFTLKIS RVEAEDVGMY FCQQSRKLPW TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H132-L218, H145-H201, H224-H'224, H227-'227, H259-H319, H365-H423, H'22-H'96, H'132-L'218, H'145-H'201, H'259-H'319, H'365-H'423, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-Toll-like receptor 2 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancer and myelodysplastic syndrome
TARGET      TLR2 (CD282) [HSA:7097] [KO:K10159]
  PATHWAY   hsa04620(7097)  Toll-like receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Pattern recognition receptors
               Toll-like receptors
                TLR2 (CD282)
                 D11503  Tomaralimab (USAN)
DBLINKS     CAS: 1449294-76-1
            PubChem: 384585479
///
